Researchers at the Moffitt Cancer Center have developed a genomics model called genomic-adjusted radiation dose (GARD) that can guide the radiation dose to match a specific tumor’s radiosensitivity. The model is expected to provide a framework for designing future clinical trials in radiation oncology
http://www.ajmc.com/newsroom/using-a-tumors-genomic-signature-to-guide-radiation-therapy-doses
Using a Tumor’s Genomic Signature to Guide Radiation Therapy Doses